CHICAGO, June 24, 2025 /PRNewswire/ -- The HLA Typing Market size is projected to be valued at USD 1,097.9 million in 2023 and reach USD 1.7 billion by 2030, growing at a CAGR of 6.7% according to a ...

This study did not confirm that UHR 12 out of 12 HLA matching increases the probability of overall survival but does demonstrate that aGVHD risk, and in certain settings TRM, is lowest in UHR ...

Matching donors for stem cell transplantation demands both precision and speed, especially as requests for high-resolution human leukocyte antigen (HLA) data grow. As labs adapt to higher workloads ...

The HLA typing market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the growth include the rising demand for organ transplantation, advancements in molecular ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

The aim of this study was to establish a novel approach for human leukocyte antigen (HLA)-typing from formalin-fixed paraffin-embedded-derived DNA. HLAs can be a prognostic factor in cancer and have ...

Major factors influencing the growth of the market. Leading players & Business Strategies. Geographic Overview. Market growth influenced due to following factors- Increasing number of HLA typing ...

DELRAY BEACH, Fla., June 2, 2025 /PRNewswire/ -- The global HLA Typing Market, valued at US$1.6 billion in 2024 stood at US$1.7 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% ...

CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today ...

From March 1999 to September 2005, a total of 65 patients (58 children, seven adults) transplanted with unrelated UCB from Guangzhou Cord Blood Bank at 24 transplant centers in China (see ...